| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |